Controlled Drugs and Substances Act Loi Réglementant Certaines

Total Page:16

File Type:pdf, Size:1020Kb

Controlled Drugs and Substances Act Loi Réglementant Certaines CANADA CONSOLIDATION CODIFICATION Controlled Drugs and Loi réglementant Substances Act certaines drogues et autres substances S.C. 1996, c. 19 L.C. 1996, ch. 19 Current to October 27, 2015 À jour au 27 octobre 2015 Last amended on July 16, 2015 Dernière modification le 16 juillet 2015 Published by the Minister of Justice at the following address: Publié par le ministre de la Justice à l’adresse suivante : http://laws-lois.justice.gc.ca http://lois-laws.justice.gc.ca OFFICIAL STATUS CARACTÈRE OFFICIEL OF CONSOLIDATIONS DES CODIFICATIONS Subsections 31(1) and (2) of the Legislation Les paragraphes 31(1) et (2) de la Loi sur la Revision and Consolidation Act, in force on révision et la codification des textes législatifs, June 1, 2009, provide as follows: en vigueur le 1er juin 2009, prévoient ce qui suit : Published 31. (1) Every copy of a consolidated statute or 31. (1) Tout exemplaire d'une loi codifiée ou d'un Codifications consolidation is consolidated regulation published by the Minister règlement codifié, publié par le ministre en vertu de comme élément evidence under this Act in either print or electronic form is ev- la présente loi sur support papier ou sur support élec- de preuve idence of that statute or regulation and of its contents tronique, fait foi de cette loi ou de ce règlement et de and every copy purporting to be published by the son contenu. Tout exemplaire donné comme publié Minister is deemed to be so published, unless the par le ministre est réputé avoir été ainsi publié, sauf contrary is shown. preuve contraire. Inconsistencies (2) In the event of an inconsistency between a (2) Les dispositions de la loi d'origine avec ses Incompatibilité in Acts consolidated statute published by the Minister under modifications subséquentes par le greffier des Parle- — lois this Act and the original statute or a subsequent ments en vertu de la Loi sur la publication des lois amendment as certified by the Clerk of the Parlia- l'emportent sur les dispositions incompatibles de la ments under the Publication of Statutes Act, the orig- loi codifiée publiée par le ministre en vertu de la pré- inal statute or amendment prevails to the extent of sente loi. the inconsistency. NOTE NOTE This consolidation is current to October 27, 2015. Cette codification est à jour au 27 octobre 2015. Les The last amendments came into force on Ju- dernières modifications sont entrées en vigueur ly 16, 2015. Any amendments that were not in force le 16 juillet 2015. Toutes modifications qui n'étaient as of October 27, 2015 are set out at the end of this pas en vigueur au 27 octobre 2015 sont énoncées à la document under the heading “Amendments Not in fin de ce document sous le titre « Modifications non Force”. en vigueur ». TABLE OF PROVISIONS TABLE ANALYTIQUE Section Page Article Page An Act respecting the control of certain Loi portant réglementation de certaines drugs, their precursors and other drogues et de leurs précurseurs ainsi que substances and to amend certain other d’autres substances, modifiant certaines Acts and repeal the Narcotic Control Act lois et abrogeant la Loi sur les stupéfiants in consequence thereof en conséquence SHORT TITLE 1 TITRE ABRÉGÉ 1 1 Short title 1 1 Titre abrégé 1 INTERPRETATION 1 DÉFINITIONS ET INTERPRÉTATION 1 2 Definitions 1 2 Définitions 1 3 Interpretation 4 3 Interprétation 4 PART I PARTIE I OFFENCES AND PUNISHMENT 4 INFRACTIONS ET PEINES 4 PARTICULAR OFFENCES 4 INFRACTIONS PARTICULIÈRES 4 4 Possession of substance 4 4 Possession de substances 4 5 Trafficking in substance 6 5 Trafic de substances 6 6 Importing and exporting 8 6 Importation et exportation 8 7 Production of substance 9 7 Production 9 7.1 Possession, etc., for use in production of 7.1 Possession etc., pour utilisation dans la or trafficking in substance 11 production ou le trafic 11 NOTICE 11 AVIS 11 8 Notice 11 8 Avis 11 REPORT TO PARLIAMENT 12 RAPPORT AU PARLEMENT 12 9 Review 12 9 Examen 12 SENTENCING 12 DÉTERMINATION DE LA PEINE 12 10 Purpose of sentencing 12 10 Objectif 12 PART II PARTIE II ENFORCEMENT 14 EXÉCUTION ET MESURES DE CONTRAINTE 14 SEARCH, SEIZURE AND DETENTION 14 PERQUISITIONS, FOUILLES, SAISIES ET RÉTENTION 14 11 Information for search warrant 14 11 Mandat de perquisition 14 12 Assistance and use of force 15 12 Assistance et usage de la force 15 13 Sections 489.1 and 490 of the Criminal 13 Application des articles 489.1 et 490 du Code applicable 16 Code criminel 16 RESTRAINT ORDERS 17 ORDONNANCES DE BLOCAGE 17 14 Application for restraint order 17 14 Demande d’ordonnance de blocage 17 14.1 Management order 18 14.1 Ordonnance de prise en charge 18 15 Sections 489.1 and 490 of the Criminal 15 Application des articles 489.1 et 490 du Code applicable 19 Code criminel 19 3 Controlled Drugs and Substances — October 27, 2015 Section Page Article Page FORFEITURE OF OFFENCE-RELATED PROPERTY 20 CONFISCATION DE BIENS INFRACTIONNELS 20 16 Order of forfeiture of property on 16 Confiscation lors de la déclaration de conviction 20 culpabilité 20 17 Application for in rem forfeiture 21 17 Demande de confiscation réelle 21 18 Voidable transfers 22 18 Annulation des cessions 22 19 Notice 22 19 Avis 22 19.1 Notice 23 19.1 Avis 23 20 Application 24 20 Demandes des tiers intéressés 24 21 Appeals from orders under subsection 21 Appels 26 17(2) 26 22 Suspension of order pending appeal 26 22 Suspension d’exécution pendant un appel 26 PART III PARTIE III DISPOSAL OF CONTROLLED DISPOSITION DES SUBSTANCES SUBSTANCES 26 DÉSIGNÉES 26 24 Application for return of substance 26 24 Demande de restitution 26 25 Disposal by Minister where no 25 Défaut de demande 28 application 28 26 Security, health or safety hazard 28 26 Risque d’atteinte à la sécurité ou à la santé publiques 28 27 Disposal following proceedings 29 27 Autres cas de disposition 29 28 Disposal with consent 29 28 Disposition sur consentement 29 29 Destruction of plant 30 29 Destruction des plantes 30 PART IV PARTIE IV ADMINISTRATION AND CONTRÔLE D’APPLICATION 30 COMPLIANCE 30 INSPECTORS 30 INSPECTEURS 30 30 Designation of inspectors 30 30 Désignation d’inspecteurs 30 31 Powers of inspector 30 31 Pouvoirs des inspecteurs 30 32 Obstructing inspector 33 32 Entrave 33 PART V PARTIE V ADMINISTRATIVE ORDERS FOR ORDONNANCES CONTRAVENTIONS OF ADMINISTRATIVES POUR DESIGNATED REGULATIONS 33 VIOLATION DE RÈGLEMENTS SPÉCIAUX 33 33 Designation of regulations 33 33 Règlements spéciaux 33 34 Contravention of designated regulation 33 34 Saisine de l’arbitre 33 35 Interim order 34 35 Ordonnance provisoire 34 36 Hearing by adjudicator 34 36 Audience 34 37 Notice to appear 35 37 Avis de comparution 35 38 Proof of service 35 38 Preuve de signification 35 39 Powers of adjudicator 36 39 Pouvoirs de l’arbitre 36 40 Hearing procedure 36 40 Procédure 36 41 Determination by adjudicator 36 41 Décision de l’arbitre 36 42 Effect of order 37 42 Prise d’effet 37 43 Offence for contravention of order 37 43 Infraction 37 4 Drogues et autres substances — 27 octobre 2015 Section Page Article Page PART VI PARTIE VI GENERAL 37 DISPOSITIONS GÉNÉRALES 37 ANALYSIS 37 ANALYSE 37 44 Designation of analysts 37 44 Désignation d’analystes 37 45 Analysis 37 45 Analyse 37 OFFENCE AND PUNISHMENT 38 INFRACTION ET PEINE 38 46 Penalty 38 46 Peine 38 EVIDENCE AND PROCEDURE 38 PREUVE ET PROCÉDURE 38 47 Limitation 38 47 Prescription 38 48 Burden of proving exception, etc. 38 48 Mention des exceptions, exemptions, etc. 38 49 Copies of documents 38 49 Copies de documents 38 50 Certificate issued pursuant to regulations 39 50 Certificats réglementaires 39 51 Certificate of analyst 39 51 Certificat de l’analyste 39 52 Proof of notice 40 52 Preuve de la signification 40 53 Continuity of possession 40 53 Continuité de la possession 40 54 Copies of records, books or documents 40 54 Copies des documents 40 REGULATIONS, EXEMPTIONS AND RÈGLEMENTS, EXEMPTIONS ET INTERDICTIONS 41 DISQUALIFICATIONS 41 55 Regulations 41 55 Règlements 41 56 Exemption by Minister 47 56 Exemption par le ministre 47 56.1 Interpretation 47 56.1 Définitions 47 57 Powers, duties and functions of Minister 57 Exercice des attributions du ministre ou or Minister of Public Safety and du ministre de la Sécurité publique et de Emergency Preparedness 55 la Protection civile 55 58 Paramountcy of this Act and the 58 Incompatibilité 56 regulations 56 59 Offence of making false or deceptive 59 Déclarations fausses ou trompeuses 56 statements 56 AMENDMENTS TO SCHEDULES 56 MODIFICATION DES ANNEXES 56 60 Schedules 56 60 Pouvoir 56 PART VII PARTIE VII TRANSITIONAL PROVISIONS, DISPOSITIONS TRANSITOIRES, CONSEQUENTIAL AND MODIFICATIONS CORRÉLATIVES CONDITIONAL AMENDMENTS, ET CONDITIONNELLES, REPEAL AND COMING INTO FORCE 56 ABROGATION ET ENTRÉE EN VIGUEUR 56 TRANSITIONAL PROVISIONS 56 DISPOSITIONS TRANSITOIRES 56 61 References to prior enactments 56 61 Mentions 56 62 Sentences for prior offences 56 62 Peines pour des infractions antérieures à la présente loi 56 63 Validation 57 63 Validation 57 CONSEQUENTIAL AMENDMENTS 57 MODIFICATIONS CORRÉLATIVES 57 5 Controlled Drugs and Substances — October 27, 2015 Section Page Article Page CONDITIONAL AMENDMENTS 57 MODIFICATIONS CONDITIONNELLES 57 REPEAL 57 ABROGATION 57 COMING INTO FORCE 57 ENTRÉE EN VIGUEUR 57 *95 Coming into force 57 *95 Entrée en vigueur 57 SCHEDULE I 58 ANNEXE I 58 SCHEDULE II 65 ANNEXE II 65 SCHEDULE III 68 ANNEXE III 68 SCHEDULE IV 70 ANNEXE IV 70 SCHEDULE V 76 ANNEXE V 76 SCHEDULE VI 77 ANNEXE VI 77 SCHEDULE VII 79 ANNEXE VII 79 SCHEDULE VIII 80 ANNEXE VIII 80 AMENDMENTS NOT IN FORCE 81 MODIFICATIONS NON EN VIGUEUR 81 6 S.C.
Recommended publications
  • (12) Patent Application Publication (10) Pub. No.: US 2006/0110428A1 De Juan Et Al
    US 200601 10428A1 (19) United States (12) Patent Application Publication (10) Pub. No.: US 2006/0110428A1 de Juan et al. (43) Pub. Date: May 25, 2006 (54) METHODS AND DEVICES FOR THE Publication Classification TREATMENT OF OCULAR CONDITIONS (51) Int. Cl. (76) Inventors: Eugene de Juan, LaCanada, CA (US); A6F 2/00 (2006.01) Signe E. Varner, Los Angeles, CA (52) U.S. Cl. .............................................................. 424/427 (US); Laurie R. Lawin, New Brighton, MN (US) (57) ABSTRACT Correspondence Address: Featured is a method for instilling one or more bioactive SCOTT PRIBNOW agents into ocular tissue within an eye of a patient for the Kagan Binder, PLLC treatment of an ocular condition, the method comprising Suite 200 concurrently using at least two of the following bioactive 221 Main Street North agent delivery methods (A)-(C): Stillwater, MN 55082 (US) (A) implanting a Sustained release delivery device com (21) Appl. No.: 11/175,850 prising one or more bioactive agents in a posterior region of the eye so that it delivers the one or more (22) Filed: Jul. 5, 2005 bioactive agents into the vitreous humor of the eye; (B) instilling (e.g., injecting or implanting) one or more Related U.S. Application Data bioactive agents Subretinally; and (60) Provisional application No. 60/585,236, filed on Jul. (C) instilling (e.g., injecting or delivering by ocular ion 2, 2004. Provisional application No. 60/669,701, filed tophoresis) one or more bioactive agents into the Vit on Apr. 8, 2005. reous humor of the eye. Patent Application Publication May 25, 2006 Sheet 1 of 22 US 2006/0110428A1 R 2 2 C.6 Fig.
    [Show full text]
  • Genl:VE 1970 © World Health Organization 1970
    Nathan B. Eddy, Hans Friebel, Klaus-Jiirgen Hahn & Hans Halbach WORLD HEALTH ORGANIZATION ORGANISATION .MONDIALE DE LA SANT~ GENl:VE 1970 © World Health Organization 1970 Publications of the World Health Organization enjoy copyright protection in accordance with the provisions of Protocol 2 of the Universal Copyright Convention. Nevertheless governmental agencies or learned and professional societies may reproduce data or excerpts or illustrations from them without requesting an authorization from the World Health Organization. For rights of reproduction or translation of WHO publications in toto, application should be made to the Division of Editorial and Reference Services, World Health Organization, Geneva, Switzerland. The World Health Organization welcomes such applications. Authors alone are responsible for views expressed in signed articles. The designations employed and the presentation of the material in this publication do not imply the expression of any opinion whatsoever on the part of the Director-General of the World Health Organization concerning the legal status of any country or territory or of its authorities, or concerning the delimitation of its frontiers. Errors and omissions excepted, the names of proprietary products are distinguished by initial capital letters. © Organisation mondiale de la Sante 1970 Les publications de l'Organisation mondiale de la Sante beneficient de la protection prevue par les dispositions du Protocole n° 2 de la Convention universelle pour la Protection du Droit d'Auteur. Les institutions gouvernementales et les societes savantes ou professionnelles peuvent, toutefois, reproduire des donnees, des extraits ou des illustrations provenant de ces publications, sans en demander l'autorisation a l'Organisation mondiale de la Sante. Pour toute reproduction ou traduction integrate, une autorisation doit etre demandee a la Division des Services d'Edition et de Documentation, Organisation mondiale de la Sante, Geneve, Suisse.
    [Show full text]
  • Emergency Department Requirement for Assessment of Outpatients Who Receive Injectable Narcotics
    This is an Interior Health CONTROLLED document. A copy of this document in paper form is not controlled and should be checked against the electronic file version to ensure accuracy Administrative Policy Manual Code: AH Patient/Client Relations/Care AH0600 - EMERGENCY DEPARTMENT REQUIREMENT FOR ASSESSMENT OF OUTPATIENTS WHO RECEIVE INJECTABLE NARCOTICS 1.0 PURPOSE To promote quality care and patient safety by ensuring Outpatients are appropriately assessed by an EDP or MRP when receiving or prior to receiving an injectable Narcotic in Emergency Departments (ED) of Interior Health (IH). 2.0 DEFINITIONS EDP Emergency Department Physician MRP Most Responsible Physician Narcotic Any substance set out in the schedule or anything that contains any substance set out in the schedule in the (Narcotic Control Regulations, CRC. C., 1041), see Appendix B. Outpatient A patient who presents to the ED for care and is not hospitalized or admitted to hospital. 3.0 POLICY 3.1 Assessment and Order Required This policy applies to Narcotic injection(s) administered to Outpatients being treated for acute and/or chronic conditions at IH EDs. Narcotic injection(s) will only be administered to Outpatients when the Outpatient has been assessed by an EDP/MRP (with active privileges in the administering facility) and the EDP/MRP has written an order dated within 24 hours of the Narcotic injection being administered. NOTE: Phone orders are acceptable on the undertaking the EDP/MRP will assess the Outpatient within 24 hours of the phone order. Orders for a series of Narcotic injections in excess of 24 hours require Outpatients be reassessed by an EDP/MRP (with active privileges in the administering facility) within 24 hours of the initial order and within every 24 hours thereafter while the Narcotic injection order is in effect.
    [Show full text]
  • EB30 17 Eng.Pdf (‎932.3Kb)
    W Ü K L Ü Г!匕 A L_ Í H ORGAN¡SATION ívlОND¡ALE ORGANIZATION DE LA SANTE EXECUTIVE BOARD EB30/17 “ Thirtieth Session 28 May 1962 Provisional agenda item 3.5 ORIGINAL: ENGLISH ACTION IN RESPECT OF INTERNATIONAL CONVENTIONS ON NARCOTIC DRUGS 1 The Seventh Wcrld Health Assembly, in resolution WHA7.6, decided that the Direсtor-General, upon receipt of the appropriate expert advice, should take decisions as to the classification of substances under certain international agree- ments, and that he should inform the Executive Board of all such decisions • The Director-General accordingly has the honour to inform the Board that, after having received advice from the Expert Committee on Addiction-Producing 2 Drugs, he has forwarded to the Secretary-General of the United Nations: (l) as required by Article 1 of the Protocol of 19 November 19^*8 bringing under international control drugs outside the scope of the Convention of 13 July 19)1 for Limiting the ^Manufacture and Regulating the Distribution of Narcotic Drugs, as amended by the Protocol signed at Lake Success on 11 December 19^6, nine notifications concerning the following drugs: (-)-3-h.ydroxy-N-propargylmorphinan 3 mete thohe p taz i ne metheptazine 3 methadone-intermediate 3 moramide-intermediate 3 noracymethadol oxpheneridine pethidine-intermediate-Bpethidine-intermediate-Aj) 3 1 Handbook of Resolutions and Decisions, 5th ed” p. 19, resolution WHA7-6. 2 Twelfth Report, Expert Committee on Addiction-Producing Drugs, Section 1 published as Wld Hlth Org, techn. Rep. Ser. 229 Proposed international non-proprietary name; for chemical formula, see twelfth report, Expert Committee on Addiction-Producing Drugs published as Wld Hlth Org, techn.
    [Show full text]
  • Narcotic Drugs and Psychotropic Substances (Control) Act
    LAWS OF GUYANA Narcotic Drugs and Psychotropic Cap. 35:11 3 Substances (Control) CHAPTER 35:11 NARCOTIC DRUGS AND PSYCHOTROPIC SUBSTANCES (CONTROL) ACT ARRANGEMENT OF SECTIONS PART I PRELIMINARY SECTION 1. Short title. 2. Interpretation. PART II PROHIBITION OF POSSESSION OF AND TRAFFICKING IN NARCOTICS AND CULTIVATION OF CERTAIN PLANTS 3. Definitions for Part II. 4. Penalty for possession of narcotic. 5. Penalty for trafficking in narcotic. 6. Penalty for supply, etc., of narcotic to child or young person if death results from consumption or administration of it. 7. Penalty for bringing into prison or taking out of prison, etc., of a narcotic. 8. Penalty for cultivation of certain plants. 9. Procedure for purposes of section 8(2) to (6). 10. Power of entry in respect of State or Government lands. 11. Power of destruction of prohibited plants. 12. Penalty for certain other acts connected with narcotics. 13. Certain prescriptions to be unlawful. 14. Penalty for receiving additional narcotic or prescription without disclosure of earlier receipt. 15. Removal of name from register. L.R.O. 3/1998 LAWS OF GUYANA 4 Cap. 35:11 Narcotic Drugs and Psychotropic Substances (Control) PART III NARCOTICS IN TRANSIT SECTION 16. Definitions for Part III. 17. Prohibition against sending narcotics by post. 18. Narcotics in transit. 19. Control of Comptroller over narcotics brought into Guyana in transit. 20. Tampering with narcotics in transit. 21. Diversion in Guyana of narcotics in transit. 22. Variations in export authorisation, import authorisation or diversion certificate granted in country other than Guyana. PART IV LICENCES 23. Grant and renewal of licences.
    [Show full text]
  • On the Approximation of the Laws of the Member States Relating to Cosmetic Products (76/768/EEC )
    27 . 9 . 76 Official Journal of the European Communities No L 262/169 COUNCIL DIRECTIVE of 27 July 1976 on the approximation of the laws of the Member States relating to cosmetic products (76/768/EEC ) THE COUNCIL OF THE EUROPEAN COMMUNITIES, regards the composition, labelling and packaging of cosmetic products ; Having regard to the Treaty establishing the Euro­ pean Economic Community, and in particular Whereas this Directive relates only to cosmetic prod­ Article 100 thereof, ucts and not to pharmaceutical specialities and medicinal products ; whereas for this purpose it is necessary to define the scope of the Directive by Having regard to the proposal from the Commission, delimiting the field of cosmetics from that of phar­ maceuticals ; whereas this delimitation follows in particular from the detailed definition of cosmetic Having regard to the opinion of the European Parlia­ products, which refers both to their areas of appli­ ment ( 1 ), cation and to the purposes of their use; whereas this Directive is not applicable to the products that fall Having regard to the opinion of the Economic and under the definition of cosmetic product but are Social Committee (2 ), exclusively intended to protect from disease; whereas, moreover, it is advisable to specify that certain prod­ ucts come under this definition, whilst products Whereas the provisions laid down by law, regulation containing substances or preparations intended to be or administrative action in force in the Member ingested, inhaled, injected or implanted in the human States
    [Show full text]
  • Questions & Answers
    SERVING CANADIANS Research and Statistics Division questions & answers February 2003 www.canada.justice.gc.ca/en/ps/rs Drug Use and Offending by: Nathalie Quann, Research Analyst Q1. How has drug legislation changed recently? Table of Contents Q1. How has drug legislation changed recently? .................................................1 Since May 1997, the Controlled Drugs and Substances Act governs all drug offences in Canada. Q2. What are the most recent Canadian statistics on drug use? ............................2 Prior to 1997, the two most important federal statutes dealing with Q3. What is the public attitude towards illicit drugs were the Narcotics Control Act (NCA) and the Food and decriminalization of drugs? ...................4 Drugs Act (FDA). The Narcotics Control Act governed over 120 different types of drugs such as cocaine, heroin, opium, and Q4. What do Canadians think about the cannabis. The NCA did not distinguish one drug from another. For medical use of soft drugs? ......................5 example, cannabis and cocaine offenders were subject to the same Q5. How is the health care system affected criminal procedures and penalties. The Food and Drugs Act governed by drug use and abuse? ..........................5 the regulation of pharmaceutical drugs, food, cosmetics, and medical devices. Two parts most specifically dealt with the non-medical use Q6. How many drug offences were reported of specific drugs: Part III governed "controlled drugs" (such as by the police in 2000? ............................6 amphetamines, barbiturates, testosterone) while Part IV governed Q7. Are offenders always charged by the "restricted drugs" (such as LSD, and other hallucinogenic drugs). police when drugs are involved? ...........7 The maximum penalties were less strict under the FDA than the NCA.
    [Show full text]
  • Pharmaceutical Appendix to the Tariff Schedule 2
    Harmonized Tariff Schedule of the United States (2007) (Rev. 2) Annotated for Statistical Reporting Purposes PHARMACEUTICAL APPENDIX TO THE HARMONIZED TARIFF SCHEDULE Harmonized Tariff Schedule of the United States (2007) (Rev. 2) Annotated for Statistical Reporting Purposes PHARMACEUTICAL APPENDIX TO THE TARIFF SCHEDULE 2 Table 1. This table enumerates products described by International Non-proprietary Names (INN) which shall be entered free of duty under general note 13 to the tariff schedule. The Chemical Abstracts Service (CAS) registry numbers also set forth in this table are included to assist in the identification of the products concerned. For purposes of the tariff schedule, any references to a product enumerated in this table includes such product by whatever name known. ABACAVIR 136470-78-5 ACIDUM LIDADRONICUM 63132-38-7 ABAFUNGIN 129639-79-8 ACIDUM SALCAPROZICUM 183990-46-7 ABAMECTIN 65195-55-3 ACIDUM SALCLOBUZICUM 387825-03-8 ABANOQUIL 90402-40-7 ACIFRAN 72420-38-3 ABAPERIDONUM 183849-43-6 ACIPIMOX 51037-30-0 ABARELIX 183552-38-7 ACITAZANOLAST 114607-46-4 ABATACEPTUM 332348-12-6 ACITEMATE 101197-99-3 ABCIXIMAB 143653-53-6 ACITRETIN 55079-83-9 ABECARNIL 111841-85-1 ACIVICIN 42228-92-2 ABETIMUSUM 167362-48-3 ACLANTATE 39633-62-0 ABIRATERONE 154229-19-3 ACLARUBICIN 57576-44-0 ABITESARTAN 137882-98-5 ACLATONIUM NAPADISILATE 55077-30-0 ABLUKAST 96566-25-5 ACODAZOLE 79152-85-5 ABRINEURINUM 178535-93-8 ACOLBIFENUM 182167-02-8 ABUNIDAZOLE 91017-58-2 ACONIAZIDE 13410-86-1 ACADESINE 2627-69-2 ACOTIAMIDUM 185106-16-5 ACAMPROSATE 77337-76-9
    [Show full text]
  • Marrakesh Agreement Establishing the World Trade Organization
    No. 31874 Multilateral Marrakesh Agreement establishing the World Trade Organ ization (with final act, annexes and protocol). Concluded at Marrakesh on 15 April 1994 Authentic texts: English, French and Spanish. Registered by the Director-General of the World Trade Organization, acting on behalf of the Parties, on 1 June 1995. Multilat ral Accord de Marrakech instituant l©Organisation mondiale du commerce (avec acte final, annexes et protocole). Conclu Marrakech le 15 avril 1994 Textes authentiques : anglais, français et espagnol. Enregistré par le Directeur général de l'Organisation mondiale du com merce, agissant au nom des Parties, le 1er juin 1995. Vol. 1867, 1-31874 4_________United Nations — Treaty Series • Nations Unies — Recueil des Traités 1995 Table of contents Table des matières Indice [Volume 1867] FINAL ACT EMBODYING THE RESULTS OF THE URUGUAY ROUND OF MULTILATERAL TRADE NEGOTIATIONS ACTE FINAL REPRENANT LES RESULTATS DES NEGOCIATIONS COMMERCIALES MULTILATERALES DU CYCLE D©URUGUAY ACTA FINAL EN QUE SE INCORPOR N LOS RESULTADOS DE LA RONDA URUGUAY DE NEGOCIACIONES COMERCIALES MULTILATERALES SIGNATURES - SIGNATURES - FIRMAS MINISTERIAL DECISIONS, DECLARATIONS AND UNDERSTANDING DECISIONS, DECLARATIONS ET MEMORANDUM D©ACCORD MINISTERIELS DECISIONES, DECLARACIONES Y ENTEND MIENTO MINISTERIALES MARRAKESH AGREEMENT ESTABLISHING THE WORLD TRADE ORGANIZATION ACCORD DE MARRAKECH INSTITUANT L©ORGANISATION MONDIALE DU COMMERCE ACUERDO DE MARRAKECH POR EL QUE SE ESTABLECE LA ORGANIZACI N MUND1AL DEL COMERCIO ANNEX 1 ANNEXE 1 ANEXO 1 ANNEX
    [Show full text]
  • (12) Patent Application Publication (10) Pub. No.: US 2014/0144429 A1 Wensley Et Al
    US 2014O144429A1 (19) United States (12) Patent Application Publication (10) Pub. No.: US 2014/0144429 A1 Wensley et al. (43) Pub. Date: May 29, 2014 (54) METHODS AND DEVICES FOR COMPOUND (60) Provisional application No. 61/887,045, filed on Oct. DELIVERY 4, 2013, provisional application No. 61/831,992, filed on Jun. 6, 2013, provisional application No. 61/794, (71) Applicant: E-NICOTINE TECHNOLOGY, INC., 601, filed on Mar. 15, 2013, provisional application Draper, UT (US) No. 61/730,738, filed on Nov. 28, 2012. (72) Inventors: Martin Wensley, Los Gatos, CA (US); Publication Classification Michael Hufford, Chapel Hill, NC (US); Jeffrey Williams, Draper, UT (51) Int. Cl. (US); Peter Lloyd, Walnut Creek, CA A6M II/04 (2006.01) (US) (52) U.S. Cl. CPC ................................... A6M II/04 (2013.O1 (73) Assignee: E-NICOTINE TECHNOLOGY, INC., ( ) Draper, UT (US) USPC ..................................................... 128/200.14 (21) Appl. No.: 14/168,338 (57) ABSTRACT 1-1. Provided herein are methods, devices, systems, and computer (22) Filed: Jan. 30, 2014 readable medium for delivering one or more compounds to a O O Subject. Also described herein are methods, devices, systems, Related U.S. Application Data and computer readable medium for transitioning a Smoker to (63) Continuation of application No. PCT/US 13/72426, an electronic nicotine delivery device and for Smoking or filed on Nov. 27, 2013. nicotine cessation. Patent Application Publication May 29, 2014 Sheet 1 of 26 US 2014/O144429 A1 FIG. 2A 204 -1 2O6 Patent Application Publication May 29, 2014 Sheet 2 of 26 US 2014/O144429 A1 Area liquid is vaporized Electrical Connection Agent O s 2.
    [Show full text]
  • Dangerous Drugs Act
    MINISTRY OF THELAWS ATTORNEY OF TRINIDAD GENERAL AND AND LEGAL TOBAGO AFFAIRS www.legalaffairs.gov.tt DANGEROUS DRUGS ACT CHAPTER 11:25 Act 38 of 1991 Amended by 27 of 1994 173/1995 44 of 2000 *55 of 2000 11 of 2014 *See Note on page 2 Current Authorised Pages Pages Authorised (inclusive) by L.R.O. 1–2 .. 3–10 .. 11–12 .. 13–16 .. 17–46 .. 47–94 .. UNOFFICIAL VERSION L.R.O. UPDATED TO 31ST DECEMBER 2016 MINISTRY OF THE ATTORNEY GENERALLAWS OF AND TRINIDAD LEGAL AFFAIRS AND TOBAGOwww.legalaffairs.gov.tt 2 Chap. 11:25 Dangerous Drugs Index of Subsidiary Legislation Page Dangerous Drugs (Appointment of Inspectors) Order (LN 143/2001) … 47 Note on section 60 of Act Section 60 of the Act provides as follows: “60. (1) The following written laws are repealed: (a) the Narcotic Control Ordinance; and (b) the Narcotic Drugs and Psychotropic Substances Control Act, 1985. (2) Notwithstanding the repeal of the Ordinance and the Act referred to in subsection (1) anything done or any action taken under the Ordinance or the Act, shall be deemed to have been done or taken under the corresponding provisions of this Act.”. N.B. Subsidiary Legislation saved in respect of the above repealed statutes: 1. Dangerous Drugs Ordinance (Ch. 12. No. 6) (1950 Revised Edition)— (Repealed by Ord. No. 27 of 1961)— (a) Raw Opium and Ganja Regulations (1950 Rev. Ed.) Vol. 8 at page 521; (b) Dangerous Drugs Regulations (1950 Rev. Ed.) Vol 8 at page 515; (c) Power of Inspection Order 1963 (LN 104/1963).
    [Show full text]
  • ATP, 489 Absolute Configuration Benzomotphans, 204 Levotphanol
    Index AIDA, 495 Affinity labeling, analogs of (Cont.) cAMP, 409, 489 motphine,448 ATP, 409, 489 naltrexone, 449 [3H] ATP, 489 norlevotphanol,449 Absolute configuration normetazocine, 181 benzomotphans, 204 norpethidine, 232 levotphanol, 115 oripavine, 453 methadone and analogs, 316 oxymotphone, 449 motphine, 86 K-Agonists, 179,405,434 phenoperidine, 234 Aid in Interactive Drug Analysis, 495 piperazine derivatives, 399 [L-Ala2] dermotphin, 363 prodines and analogs, 272 [D-Ala, D-Leu] enkephalin (DADL), 68, 344 sinomenine, 28, 115 [D-Ala2 , Bugs] enkephalinamide, 347, 447 viminol, 400 [D-Ala2, Met'] enkephalinamide, 337, 346, Ac 61-91,360 371,489 Acetylcholine, 5, 407 [D-Ala2]leu-enkephalin, 344, 346, 348 Acetylcholine analogs, 186, 191 [D-Ala2] met-enkephalin, 348 l-Acetylcodeine, 32 [D-Ala2] enkephalins, 347 Acetylmethadols (a and (3) Alfentanil, 296 maintenance of addicts by a-isomer, 304, 309 (±)-I1(3-Alkylbenzomotphans, 167, 170 metabolism, 309 11(3-Alkylbenzomotphans, 204 N-allyl and N-CPM analogs, 310, 431 7-Alkylisomotphinans, 146 stereochemistry, 323 N-Alkylnorketobemidones, 431 synthesis, 309 N-Alkylnorpethidines, 233 X-ray crystallography, 327 N-Allylnormetazocine, 420 6-Acetylmotphine, receptor binding, 27 N-Allylnormotphine, 405 Acetylnormethadol, 323 N-Allylnorpethidine, 233 8(3-Acyldihydrocodeinones, 52 3-Allylprodines (a and (3), 256 14-Acyl-4,5-epoxymotphinans, 58 'H-NMR and stereochemistry, 256 7-Acylhydromotphones, 128 X-ray crystallography, 256 Addiction, 4 N-Allylnormetazocine, 420 Adenylate cyclase, 6, 409, 413, 424,
    [Show full text]